ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for its Spartan PEEK Suture Implant system (Spartan™).
Spartan is a preloaded PEEK threaded anchor indicated for use in fixation of soft tissue to bone, such as during a rotator cuff repair.
Spartan complements ArthroCare’s line of anchors which can be used with ArthroCare’s suture passing technology, such as FirstPass™. It has a unique 5.5mm, screw-in design which provides stronger pull-out strength, particularly in soft bone and can be used to perform single and double row repairs.
Spartan is manufactured from PEEK, (polyether-etherketone) a material widely used in orthopedic implants, and will be used to reattach rotator cuff tendons to bone. More than 400,000 patients undergo rotator cuff surgery annually in the U.S.
SOURCE ArthroCare Corp.